COSMO Pharmaceuticals SA (COPN) - Total Assets

Latest as of December 2025: CHF612.16 Million CHF ≈ $773.93 Million USD

Based on the latest financial reports, COSMO Pharmaceuticals SA (COPN) holds total assets worth CHF612.16 Million CHF (≈ $773.93 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See COSMO Pharmaceuticals SA shareholders equity for net asset value and shareholders' equity analysis.

COSMO Pharmaceuticals SA - Total Assets Trend (2004–2025)

This chart illustrates how COSMO Pharmaceuticals SA's total assets have evolved over time, based on quarterly financial data.

COSMO Pharmaceuticals SA - Asset Composition Analysis

Current Asset Composition (December 2025)

COSMO Pharmaceuticals SA's total assets of CHF612.16 Million consist of 29.9% current assets and 70.1% non-current assets.

Asset Category	Amount (CHF)	% of Total Assets
Cash & Equivalents	CHF0.00	9.1%
Accounts Receivable	CHF25.60 Million	4.2%
Inventory	CHF10.42 Million	1.7%
Property, Plant & Equipment	CHF0.00	0.0%
Intangible Assets	CHF325.63 Million	53.2%
Goodwill	CHF23.99 Million	3.9%

Asset Composition Trend (2004–2025)

This chart illustrates how COSMO Pharmaceuticals SA's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market cap of COSMO Pharmaceuticals SA.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: COSMO Pharmaceuticals SA's current assets represent 29.9% of total assets in 2025, an increase from 17.7% in 2004.
Cash Position: Cash and equivalents constituted 9.1% of total assets in 2025, up from 1.2% in 2004.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 56.0% of total assets, an increase from 4.0% in 2004.
Asset Diversification: The largest asset category is intangible assets at 53.2% of total assets.

COSMO Pharmaceuticals SA Competitors by Total Assets

Key competitors of COSMO Pharmaceuticals SA based on total assets are shown below.

Company	Country	Total Assets
Pfizer Inc SA:PFIZ34	Brazil	R$208.73 Billion
CSPC Pharmaceutical Group Limited F:CVG	Germany	€46.00 Billion
Aurora Optoelectronics Co Ltd SHG:600666	China	CN¥1.60 Billion
Shandong Keyuan Pharmaceutical Co. Ltd. A SHE:301281	China	CN¥1.60 Billion
Dimed S.A. Distribuidora de Medicamentos SA:PNVL3	Brazil	R$3.83 Billion
Pfizer Inc NYSE:PFE	USA	$208.73 Billion
Merck & Company Inc NYSE:MRK	USA	$129.55 Billion
Firebrick Pharma Ltd AU:FRE	Australia	AU$1.83 Million

COSMO Pharmaceuticals SA - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	7.18	4.19	11.60
Quick Ratio	6.77	3.91	11.34
Cash Ratio	0.00	0.00	0.00
Working Capital	CHF157.63 Million	CHF153.99 Million	CHF231.07 Million

COSMO Pharmaceuticals SA - Advanced Valuation Insights

This section examines the relationship between COSMO Pharmaceuticals SA's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	3.45
Latest Market Cap to Assets Ratio	2.48
Asset Growth Rate (YoY)	-5.4%
Total Assets	CHF612.16 Million
Market Capitalization	$1.52 Billion USD

Valuation Analysis

Premium Asset Valuation: The market values COSMO Pharmaceuticals SA's assets at a significant premium (2.48x), suggesting investors see substantial growth potential or unique competitive advantages.

Significant Asset Reduction: COSMO Pharmaceuticals SA's assets decreased by 5.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for COSMO Pharmaceuticals SA (2004–2025)

The table below shows the annual total assets of COSMO Pharmaceuticals SA from 2004 to 2025.

Year	Total Assets	Change
2025-12-31	CHF612.16 Million ≈ $773.93 Million	-5.35%
2024-12-31	CHF646.77 Million ≈ $817.69 Million	+16.75%
2023-12-31	CHF553.98 Million ≈ $700.38 Million	-27.07%
2022-12-31	CHF759.59 Million ≈ $960.33 Million	-5.71%
2021-12-31	CHF805.56 Million ≈ $1.02 Billion	+35.12%
2020-12-31	CHF596.16 Million ≈ $753.71 Million	+1.88%
2019-12-31	CHF585.16 Million ≈ $739.80 Million	-6.48%
2018-12-31	CHF625.69 Million ≈ $791.04 Million	+25.65%
2017-12-31	CHF497.97 Million ≈ $629.57 Million	+12.29%
2016-12-31	CHF443.47 Million ≈ $560.67 Million	+1.26%
2015-12-31	CHF437.94 Million ≈ $553.68 Million	+94.11%
2014-12-31	CHF225.62 Million ≈ $285.25 Million	-7.15%
2013-12-31	CHF243.00 Million ≈ $307.22 Million	+60.03%
2012-12-31	CHF151.84 Million ≈ $191.97 Million	+94.58%
2011-12-31	CHF78.04 Million ≈ $98.66 Million	-15.01%
2010-12-31	CHF91.83 Million ≈ $116.09 Million	+28.49%
2009-12-31	CHF71.46 Million ≈ $90.35 Million	+23.72%
2008-12-31	CHF57.77 Million ≈ $73.03 Million	+22.31%
2007-12-31	CHF47.23 Million ≈ $59.71 Million	+100.03%
2006-12-31	CHF23.61 Million ≈ $29.85 Million	-16.31%
2005-12-31	CHF28.21 Million ≈ $35.67 Million	+20.24%
2004-12-31	CHF23.46 Million ≈ $29.66 Million	--

About COSMO Pharmaceuticals SA

SW:COPN Switzerland Drug Manufacturers - General

Market Cap

$1.78 Billion

CHF1.40 Billion CHF

Market Cap Rank

#7338 Global

#101 in Switzerland

Share Price

CHF82.00

Change (1 day)

-0.36%

52-Week Range

CHF48.35 - CHF124.80

All Time High

CHF171.24